You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LGND Exercise Disclosure
Reardon Andrew · SEC Form 4 · Filed Jun 2, 2026
Exercise
Calculated transaction value
$261.35K
Reardon Andrew CLO & Secretary
LGND
Transaction date
Jun 1, 2026
Public filing date
Jun 2, 2026
Filing lag
Filed 1 day later
LGND daily price context
Close on/before transaction
$229.78
Jun 1, 2026
First close after public filing
$234.4
Jun 3, 2026
30-day return after filing
+36.33%
Through Jul 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,000 shares @ $52.27
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002001011-26-000083
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$1.4M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ligand Pharmaceuticals Inc LGND Current | Exercise | Jun 1, 2026 | $261.35K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 1, 2026 | $323.59K |
| Ligand Pharmaceuticals Inc LGND | Exercise | Jun 1, 2026 | $0 |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 1, 2026 | $109.96K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 1, 2026 | $152.46K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 1, 2026 | $90.71K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 1, 2026 | $133.49K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 1, 2026 | $279.03K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 1, 2026 | $46.08K |